This review discusses the evidence in support of the use of Stiripentol, its pharmacological properties, dosage and administration, and efficacy and tolerability as demonstrated in pivotal clinical trials.
It also provides commentary and recommendations from Laureate Professor Ingrid Scheffer AO, a physician-scientist working as a paediatric neurologist and epileptologist at the University of Melbourne and Austin Health.
Please login below to download this issue (PDF)